Search

MORE NEWS
HEALTHCARE | Tony Chua, Singapore
Published: 07 Apr 11
1529 views


A*STAR scientists join forces with Servier to develop anti-cancer drugs

The partnership aim to develop drugs restricting the growth of tumor-initiating cells in breast cancer.

A*STAR’s Singapore Immunology Network (SIgN) has inked a Research Collaboration Agreement (RCA) with Servier, the second largest French pharmaceutical company in the world. The collaboration aims to develop anti-cancer drugs to suppress tumor-initiating cells (TICs), often called “cancer stem cells”. By targeting TICs, scientists hope to be able to prevent relapse and metastatic outgrowth in cancer patients.

Under this three-year partnership, SIgN and Servier aim to develop drugs directed at restricting the growth of TICs in breast cancer - the most common cancer in women all over the world, and also in Singapore with about 1,100 new cases diagnosed each year. Scientists at SIgN, with their expertise in tumour immunology and therapeutic antibodies, will be able to isolate TIC-specific human monoclonal antibodies, and with the help of Servier, develop them into anti-cancer drugs, accordinbg to an A*STAR report.

As Associate Professor Jean-Pierre Abastado, Principal Investigator of SIgN that will head the lab for this SIgN-Servier collaboration said, “Scientists and clinicians have been trying to understand why cancer relapse occurs in spite of the removal of the primary tumor. Basic research conducted at SIgN has shown that cancer relapse could potentially be avoided by controlling TICs. Our task at hand is to discover the monoclonal antibodies that will target these TICs.”

Dr. Emmanuel Canet, MD PhD, Head of Research & Development at Servier added, “This partnership exemplifies our vision to collaborate with leading scientists worldwide to discover and develop innovative medicines in the field of cancer where the medical need is still huge. We have been very impressed by the quality of the research work done at the Singapore Immunology Network (SIgN), which we believe is one of the best such institutes in the world.”

“Elimination of tumour initiating cells represents a major challenge in oncology. The aim of this collaboration is to develop an innovative approach to identify membrane neo-antigens specifically expressed by breast cancer stem cells. There is a great therapeutic potential since therapeutic antibodies against these neo-antigens could be used to control the residual disease by eliminating cancer stem cells persisting after conventional therapies", said Dr Stéphane Depil, MD PhD, director of Oncology Research & Development Unit at Servier.”

Prof Paola Castagnoli, Scientific Director of SIgN added “This project is supported by a joint lab between Servier and us and it will be located within SIgN. This is a strategy that we have already successfully developed last year with another company, in the field of Infectious Diseases. Pharma companies are very interested to develop new projects where they can find both an excellent scientific environment, together with unique technology platforms such as our fully human Monoclonal Platform and our Immuno-monitoring platform that can speed up the process of drug discovery.”

Chairman of SIgN, Prof Philippe Kourilsky commented, “I believe that this partnership with Servier will soon lead to the discovery of novel cancer drugs that will effectively control cancer relapse, enhancing the survival of cancer patients. I’m particularly delighted that this work stems from the results of basic research in Tumour Immunology conducted at SIgN. This partnership with Servier was made possible thanks to the powerful human monoclonal antibody platform that we have developed. This is an excellent example of how public research institutes and private companies can leverage on each other’s strength to come up with innovative solutions to address pressing medical needs such as fighting cancer effectively.”



Sign up for our newsletter

 

Do you know more about this story? Contact us anonymously through this link.

Click here to learn about advertising, content sponsorship, events & rountables, custom media solutions, whitepaper writing, sales leads or eDM opportunities with us.

To get a media kit and information on advertising or sponsoring click here.

Tags: A*STAR Servier, A*STAR Servier research, A*STAR Servier cancer drug research

LATEST HEALTHCARE JOBS »
  • No jobs posted on this category.
PRINT ISSUE »

Subscribe Now
What factors are keeping expats rooted in Singapore?

772 views

What factors are keeping expats rooted in Singapore?

525 views

Can Asian private equity outgrow the west?

205 views

MOST READ EXCLUSIVES

16 items that are a tad cheaper in Singapore than in Hong Kong

16 items that are a tad cheaper in Singapore than in Hong Kong

Coffee lovers need not go farther for a cheaper cup of cappuccino.

by KRISANA GALLEZO
20 Mar 2015 | 56339 views
 

Singapore’s first permanent lifestyle market opens in Bukit Timah

Singapore’s first permanent lifestyle market opens in Bukit Timah

Over 20 brands and labels are gathered together under one roof.

by KRISANA GALLEZO
5 Jan 2015 | 35634 views

Singapore Business Review’s 2014 Class of 40 and under

Singapore Business Review’s 2014 Class of 40 and under

Meet a summa cumlaude graduate who rises from poverty to become JP Morgan’s head of corporate finance.

by KRISANA GALLEZO
12 Jan 2015 | 33490 views
 

Chow Tai Fook opens second store in Singapore

Chow Tai Fook opens second store in Singapore

It's a 1,000-square feet new jewellery shop on Orchard Road.

by KRISANA GALLEZO
26 Feb 2015 | 11137 views

This food hub in Seah Street brings a throwback experience to dining

This food hub in Seah Street brings a throwback experience to dining

It offers an exciting lunch menu which changes every week.

by KRISANA GALLEZO
16 Jan 2015 | 7396 views
 

This is a woman’s world: CRIB launches Singapore’s first business and lifestyle incubator for women

This is a woman’s world: CRIB launches Singapore’s first business and lifestyle incubator for women

Find out what the three key platforms of CRIB are.

by KRISANA GALLEZO
10 Mar 2015 | 7370 views

The New Black hits Singapore with rarest green coffee

The New Black hits Singapore with rarest green coffee

It also boasts of its Impossible Collection curated by the ‘world’s rockstar roasters'.

by KRISANA GALLEZO
5 Mar 2015 | 4022 views
 

Check out this integrated office cum lab of Friesland Campina in Singapore

Check out this integrated office cum lab of Friesland Campina in Singapore

A curved glass wall resulted in a 90% open-plan office.

by KRISANA GALLEZO
17 Feb 2015 | 3971 views

Too many business cards? Why don’t you try Sansan’s business card management service?

Too many business cards? Why don’t you try Sansan’s business card management service?

After Singapore, this contract management company plans to expand in the APAC region.

by KRISANA GALLEZO
12 Feb 2015 | 3821 views
 

This startup created the world’s first bed sensor technology

This startup created the world’s first bed sensor technology

No more patients accidentally falling off hospital beds.

by KRISANA GALLEZO
14 Jan 2015 | 3252 views

Spencer Ogden gets funky with its newest trademark space in Singapore

Spencer Ogden gets funky with its newest trademark space in Singapore

The company invested over $1M to make this signature office possible.

by KRISANA GALLEZO
5 Feb 2015 | 3114 views
 

Meet INSEAD’s new chairman of the board

Meet INSEAD’s new chairman of the board

Find out how Andreas Jacobs plans to bring “business as a force for good”.

by KRISANA GALLEZO
14 Jan 2015 | 2486 views

What it’s like going into business with your significant other

What it’s like going into business with your significant other

A couple who founded an artisanal food outlet, P.Bistro, shares experience.

by KRISANA GALLEZO
9 Jan 2015 | 2132 views
 

LawCanvas saves the day: Easy legal documents in under a minute

LawCanvas saves the day: Easy legal documents in under a minute

The founders revolutionized the legal industry despite having different backgrounds.

by KRISANA GALLEZO
2 Mar 2015 | 1931 views

MetLife builds its first global R&D hub

MetLife builds its first global R&D hub

It bills itself as a first-of-its-kind innovation centre for the insurance industry.

by KRISANA GALLEZO
26 Jan 2015 | 1604 views
 

PocketMath makes buying mobile ad impressions easier

PocketMath makes buying mobile ad impressions easier

It integrates over 20 ad exchanges and offers over 20B impressions a day.

by KRISANA GALLEZO
9 Feb 2015 | 1589 views

The heat is on: This office literally gets a bit hot for their green drive

The heat is on: This office literally gets a bit hot for their green drive

Discover how they execute their green initiatives in the office.

by KRISANA GALLEZO
22 Jan 2015 | 1466 views
 

Want to be hands-on with your ideal home setting?

Want to be hands-on with your ideal home setting?

Commune is opening an Experience Centre for meticulous homeowners.

by KRISANA GALLEZO
23 Mar 2015 | 1349 views

Here’s how migrants can be sure their loved ones back home paid the doctor a visit

Here’s how migrants can be sure their loved ones back home paid the doctor a visit

This NRI-focused startup also gives migrants monthly feedback from the doctor.

by KRISANA GALLEZO
7 Jan 2015 | 1223 views
 

FTMSGlobal Academy Singapore launches new weekend MBA

FTMSGlobal Academy Singapore launches new weekend MBA

The course fee is below $20,000.

by KRISANA GALLEZO
8 Jan 2015 | 1223 views

What is the future of the sports business in Singapore?

What is the future of the sports business in Singapore?

Can a new billion-dollar stadium give Singapore the edge it needs to compete for world-class sporting events?

by STAFF REPORTER
20 Mar 2015 | 368 views
 
close Don't Show Again

STAY INFORMED! Get our free weekly newsletter